3 American Stocks Showing the Same Setup That Sent Moderna Up 177%

Moderna, the American pharma company that became popular for its COVID vaccine, has spent three days trading like a meme stock. Shares exploded 177% on Wednesday after its personalized mRNA cancer vaccine with Merck succeeded in a Phase 3 melanoma trial, adding roughly $30 billion in market value in a single session.  Heavy short covering The post 3 American Stocks Showing the Same Setup That Sent Moderna Up 177% appeared first on BeInCrypto.